chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Itchiness around the injection site; Redness around the injection site; Soreness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness around the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and VACCINATION SITE PAIN (Soreness around the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Neck pain. Concomitant products included ATORVASTATIN for Cholesterol, METFORMIN for Diabetes, PREGABALIN (LYRICA) for Neck pain.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness around the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and VACCINATION SITE PAIN (Soreness around the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PRURITUS (Itchiness around the injection site), VACCINATION SITE ERYTHEMA (Redness around the injection site) and VACCINATION SITE PAIN (Soreness around the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated she stopped taking the Lyrica for neck pain because it was not working. Patient reported she had a big red circle around her injection site. The patient rubbed alcohol on it and took a Tylenol.
On the evening of 3/6/01, pt developed a temperature of 104.6 and difficulty breathing.
Hives several hours, post vax. Also introduced Enfamil and oatmeal for the first time. Had rxn immediately after Enfamil.
Pt called office c/o 2 days fever (did not take temperature), chills, joint pain, swollen glands in neck and stomach cramps, no rash.
Redness, slight swelling and itchiness appeared in the afternoon of 01/18/21 I am also feeling a bit tired and have some headache.  Redness not itchiness were not there until 01/18/21
Headache, Myalgia, fever, chills, sore throat, fatigue Narrative: took tylenol
Patient is a 67 y.o. female patient of, CNP with history of COVID lung cancer CHF CAD hypothyroidism presented to Hospital with worsening shortness of breath.   Acute on chronic respiratory failure with hypoxia POA Possible community-acquired pneumonia POA Possible radiation pneumonitis POA COVID-19 POA Patient uses 3 L at bedtime Currently requiring 4 L Cough suppressant Wean oxygen as tolerated Patient tested positive for COVID about 3 weeks ago.   Influenza negative CT scan did not show evidence of pulmonary embolism.  However showed patchy bilateral predominantly peripheral lung opacities consistent with known history of COVID. Legionella and strep antigens sent Blood culture done in the ED, no growth to date, follow results Urine culture with no growth, continue to follow results Check COVID and influenza tests.  COVID is positive but likely residual from previous infection.  Influenza is negative   Severe Sepsis present on admission, resolved Source community-acquired pneumonia Radiation pneumonitis Long COVID Due to tachycardia and tachypnea Patient was given Zosyn in the ED with allergic reaction that responded to Benadryl.  Start ceftriaxone and azithromycin Check urine antigens CT with multifocal infiltrates which can be seen in COVID pneumonia We will give decadron 6mg x 6 days  given worsening hypoxia   Lactic acidosis Likley in the setting of sepsis Cautious use of fluids.      Chronic systolic congestive heart failure CAD Hyperlipidemia Atrial fibrillation Stents in December 2022 Brilinta metoprolol Brilinta indefinitely per cardiac documentation EF of 40% One time dose of 40 lasix, continue with IV or transition to home oral dose as needed Metoprolol Entresto Lung cancer Follows with Dr.  Just finished radiation treatment
Left upper arm progressive redness, warmth and pain, distal to injection site.  Reported fever to 101. Treated with Tylenol and ice.
Parosmia. Smell of sewage 3 days after the 1st dosage of pfizer. Many foods and smells were changed, like lemon coffee avocado cilantro alcohol perfumes. Almost 10 months later and my sense of smell is better. But some foods like Cilantro are still terrible.
Patient lost sense of taste within 2 days of the vaccine and developed partial facial paralysis of the right side within 4 days of receiving the vaccine
Neck pain,  pain going down right arm, numbness, tingling of finger.  Saw Dr., 11/18/21. Pinch nerve.  About 3 -4 weeks since started. Told to continue to rotate Tylenol and ASA. Use heating pad , schedule  physical therapy , scheduled for 1 available appointment, December 13th. Saw on 12 day course of prednisone. , restarted 2nd course of prednisone 11/30/21
Patient developed hives after second Pfizer Covid 19 vaccine. Reports having taken OTC Benadryl and problem resolved in 2 days.
suspected vaccination failure; Third time; painful; This case was reported by a consumer via interactive digital media  and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient did have a shingles shot for Shingles but it didn't help. This was a very painful disease. The patient experienced shingles 3rd case, while surgery on knee, 2 new Knee. The patient kept it quiet. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided. For tolerance of 1st and 2nd occurrence of shingles refers case US2021AMR187315 and US2021AMR187329 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR187315:same reporter US-GLAXOSMITHKLINE-US2021AMR187329:same reporter
auto immune disease; nerve damage; got sick; had a allergic reaction to it; This case was reported by a consumer via interactive digital media and described the occurrence of autoimmune disorder in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) for prophylaxis and PNEUMOCOCCAL VACCINE (PNEUMONIA SHOT) for prophylaxis.   Concurrent medical conditions included immunocompromised.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season, Influenza vaccine Quadrivalent 2019-2020 season and PNEUMONIA SHOT. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season and not applicable after receiving Influenza vaccine Quadrivalent 2019-2020 season, the patient experienced autoimmune disorder (serious criteria disability and GSK medically significant), nerve damage (serious criteria disability), malaise and allergic reaction. On an unknown date, the outcome of the autoimmune disorder, nerve damage, malaise and allergic reaction were unknown.   It was unknown if the reporter considered the autoimmune disorder and nerve damage to be related to Influenza vaccine Quadrivalent unspecified season. The reporter considered the malaise and allergic reaction to be related to Influenza vaccine Quadrivalent 2019-2020 season.  Additional details were provided as follows: The age at vaccination was not reported. The patient took the flu vaccine last year and for the time got sick and had a allergic reaction to it .  The patient used to take the flu shot every year and the pneumonia shot every 3 or 4 years because of low immune system and other health issues.  The patient experienced enough Auto Immune Diseases and Permanent Disability/Nerve Damage.
Chills, Injection site soreness,  fatigue, (possible fever) did not record temperature, dizziness and headache.
After the booster, I was very tired like I was coming down with flu and slept most of the day. UTI symptoms started a week - 22Nov2021. Frequent urination, mild burning sensation and progressed to cloudy urine and blood in urine. On 27Nov2021, I did telehealth. Diagnosed as UTI. Had UTI years before and earlier this year prior to the vaccination.
17 year old male got the 1st dose of the moderna vaccine; A spontaneous report was received from a Health care professional concerning a 17-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) before 18 years of age.  The patient's medical history was not provided by the reporter. No concomitant medications was reported.  On an unknown date, the patient received their first of two planned doses of mRNA-1273 (Lot number: 026L20A) intramuscularly in left deltoid for prophylaxis of COVID-19 infection.   On an unknown date, the HCP reported that the patient was vaccinated at 17 years of age (Product administered to patient of inappropriate age).  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event is resolved.; Reporter's Comments: This case concerns a 17-year-old male patient who received their first of two planned doses of mRNA-1273 (Lot 026L20A), reporting Product administered to patient of inappropriate age without any associated adverse events.
Tinnitus Ongoing, high pitched ringing in both ears. Sometimes with 2 tones, one higher, one lower.
Extreme pain in my arm. The pain got so bad that I was unable to move my arm at all. Was placed on a steroid treatment which helped until I was off of the steroid and the horrible pain returned. I was put back on another steroid treatment which again worked while I was on it, but the pain is returning again.
Temp neck pain - headache, vomited - body aches - arm edema.  9/5/08 Reviewed PCP office records of 8/21/08 which reveal patient experienced neck pain & HA, afebrile.  FINAL DX: Vaccine reaction.
Information has been received from a company representative concerning a child who was vaccinated "a few years ago" with one dose of MMR live. Subsequently, the patient developed encephalitis "which the mother connected to the vaccine." The patient sought unspecified medical treatment. Upon medical review, the patient's experience was considered an "other medical event". Follow-up information received from a physician indicated that the patient had a "possible reaction to DTP" and that the mother did not want any other vaccines given to her other child. No further information is expected.
That nite started having diarrhea and vomiting and headache. This has continued and she does not seem to be better. Doctor said she was having a severe reaction to the flu shot. Put on Zofran.
While sitting on the toilet going to the bathroom, the patient was observed to start tremor like activity x 2, lasting 3 min.
Immediate onset of swelling pain pruritis at the injection site; continued to well for 72 hours.
Breakthrough case admission after 2 vaccines Moderna 8/17/21 lot# 005C21A;  Moderna 9/16/21 lot# 005C21A
Patient reported SIRVA in left arm following COVID-19 vaccination. Patient described swelling in shoulder and severe pain. He was seen by ortho on 12/6/2021. Fluid removed and patient reported feeling better.
Narrative:  This started 2/14/22 when he got shingles vaccine in his right arm. Had right arm swelling and pain, accompanied by left lower chest wall pain with movement. Nonextertional chest pain, nonradiating, nonmigratory, nonpositional. Went to hospital where he states he was discharged on antibiotics (PCP message says
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 61-year-old male patient who received SHINGRIX. Co-suspect products included PNEUMONIA VACCINE. Previously administered products included shingles vaccine with an associated reaction of herpes zoster. On 17th May 2018, the patient received the 1st dose of SHINGRIX and the 1st dose of pneumonia vaccine. In May 2018, less than a month after receiving SHINGRIX, the patient experienced injection site erythema, injection site swelling and muscle soreness. On an unknown date, the patient experienced influenza like illness and malaise. The patient was treated with Aspirin (baby), NIASPAN and vitamin. On an unknown date, the outcome of the injection site erythema, injection site swelling, muscle soreness, influenza like illness and malaise were unknown. It was unknown if the reporter considered the injection site erythema, injection site swelling, muscle soreness, influenza like illness and malaise to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient's wife. Both of them had received the SHINGRIX vaccine and experienced similar reactions. The patient's local reaction was not as bad like what his wife experienced and only last about 2 days with muscle soreness, redness. The patient was not hospitalized. This case has been linked with US2018GSK095562, reported by the same reporter.
Apprx 4 hours following flu shot administration client was experiencing, sore throat, cough & SOB a discomforting sensation.
Sore arm, headache, temperature of 101*F, body aches, sore throat
Fatigue/mostly tired; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue/mostly tired) and HEADACHE (Headache) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 029K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue/mostly tired) and HEADACHE (Headache). At the time of the report, FATIGUE (Fatigue/mostly tired) and HEADACHE (Headache) outcome was unknown.            No Concomitant product use was reported. No treatment information was provided.  After second dose, the patient experienced fatigue, headache and was mostly tired.   This case was linked to MOD-2021-373466, MOD-2021-373427 (Patient Link).
No adverse effects reported; patient received one dose of PNEUMOVAX 23 approximately 4-5 months too early; This spontaneous report was received from a pharmacist and refers to a 79-year-old female patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 10-OCT-2019, the patient was vaccinated with one dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (lot # S021740, expiry date 25-MAR-2021) (exact dose and route of administration were not reported) for prophylaxis, approximately 4-5 months too early. No adverse effects were reported. The outcome of the event was unknown.
Dizzy, headache, full body muscle aches, chills (over 36 hours), elevated temperate, tightness in the chest, fatigue.  Symptoms started mild and by 12 hours after the shot full flu like symptoms last for over 48 hours.  Did not subside until the Friday after the shot (60 hours after the shot).  No treatment except rest and drinking plenty of fluids.
Local reaction at site of DTaP. Redness and swelling size of grapefruit.
Today I received a expired vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Today I received a expired vaccine.) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 3005836) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Today I received a expired vaccine.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Today I received a expired vaccine.) outcome was unknown. Not Provided          No Concomitant medication reported. No Treatment medication reported.
Extreme teeth chattering chills, very tired, then a fever developed in the afternoon that ranged from 99.5 to 101.2.  The fever didn't break until the morning of 12/15/2022.
Information regarding Flumist (2003-2004 Formula) (influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (frozen)) was received from a consumer regarding a 7-year-old male patient who experienced fever and cold symptoms. At 7 years of age, the patient received a dose on 06-Nov-2003. Medical History: The patient had no relevant medical history. Product Details: Indication for Flumist (2003-2004 Formula) was immunization. Product was administered on 06-Nov-2003. Dose regimen was 1 dose 1 times per day (intranasal). Concomitant Therapy: Concomitant medications were not reported. Event Details: The patient developed the cold symptoms (nasopharyngitis) of a runny nose and fever (pyrexia) and on 08-Nov-2003. The patient's mother indicated that as of 11-Nov-2003, the symptoms were improving. Related Case(s): The patient's brother developed a runny nose on 11-Nov-2003, after being in close contact with the patient post-vaccination. The infant had also received an influenza virus vaccine injection (manufacturer unknown) on 06-Nov-2003 (see MCN HQWYE019612NOV03). No additional information was available at the date of this report.
11/17 - Flu shot 8:45am 11/17 - 4pm cold, chills, shakes 11/17 - 6:15pm 105 degree fever - taken to ED via ambulance - given IV-fluids, LEVAQUIN for pneumonia, UTI & flu shot reaction.
Pt recvd Td vax & devel redness & swelling @ the inject site w/spreading to appendix area, groin, top of leg; area also red & hot @ noc; 3/4 of back turned yellow, w/devel of a red outline; redness & induration;
Pt developed redness, warmth and tenderness at shot site (right leg) 3 days after administration. Given Augmentin PO with improvement within 48 hrs.
This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a 59-year-old female patient who received FLUARIX QUADRIVALENT for prophylaxis. On 5th October 2018, the patient received FLUARIX QUADRIVALENT (intramuscular). On 5th October 2018, less than a day after receiving FLUARIX QUADRIVALENT, the patient experienced injection site pain. On 9th October 2018, the patient experienced neck pain and shoulder pain. On an unknown date, the outcome of the injection site pain, neck pain and shoulder pain were unknown. It was unknown if the reporter considered the injection site pain, neck pain and shoulder pain to be related to FLUARIX QUADRIVALENT. Additional details were reported as follows: The patient received Quadrivalent flu vaccine. She thought it was FLUARIX QUADRIVALENT, but was not certain. On 9th October 2018, 4 days after vaccination, the patient started having pain radiating up from the injection site, up her neck and into her shoulder towards the back side. The patient had not done anything to account for this new pain and thought it was due to her flu vaccine. She had tried heating patches and a TENS unit, but neither had helped the pain.
Patient positive for COVID-19 on 04/23/21 after completing vaccination. She had nonproductive cough, shortness of breath, and fevers.
Immunization given at 9:05 pm, at 9:20 pm patient husband alerted staff that patient had passed out.  Nurse entered room, patient was sitting on floor awake.  Patient then vomited x2.  Patient complained of feeling "dizzy, hot flashes, and room spinning".  Nurse observed hives/red rash starting above right breast up to right ear.  EMS called at 09:20pm while nurse took vital signs.  SPO2 98, pulse 95, glucose 98, BP 132/88.  Patient also reported itching and was observed scratching rash. EMS arrived at 09:30pm, evaluated patient.  Patient refused treatment due to insurance not covering.  This nurse urged patient and husband to go to the ER.  Patient left facility at 09:45pm. in personal vehicle.
3 1/2-4 hrs inconsolable high pitched cry; couldn't lay down sl fever;
Patient has been having above the chest tightness. finds it hard to explain but onset night of flu shot couple hours after. She feels it is worse when she bends over to pick something up.
pt recv vax;devel aches in all muscles & joints,minor soreness in inject site;felt "drunk" w/staggering gait & incoordination;later,numbness in fingers,numb & cold;inc fatigue;feel asleep p/getting in car,"too tired to drive";dph;resolved
Painful throat, swelling of nasal, sinus, throat passages, fatigue, malaise, depression,
Information has been received from a physician concerning his/her 12 year old daughter who at 9 year old was vaccinated with the first dose of GARDASIL (route and LOT # not reported). After receiving the vaccine, the patient developed a rash. The rash had cleared but skin hypopigmentation at the area had occurred. The area was 3 to 5 inches in circumference and located at the site of injection. Unspecified medical attention was sought. The patient's skin hypopigmentation was not recovered. She was not going to continue with the series. No further information is available.
she had quite a rash, it was red, right where the injection was made; it was warm; her arm was hurting a bit; slight headache; This is a spontaneous report from a contactable consumer (patient) and contactable physician.  A 78-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9263), via an unspecified route of administration at arm left on 22Jan2021 at single dose for COVID-19 immunization.  The patient medical history included COVID-19 (with symptoms: terrible headache, cough, shortness of breath for good 6 weeks and fatigue) from Nov2020 to an unknown date.  The patient experienced slight headache on 23Jan2021, her arm was hurting a bit on 25Jan2021. On 26Jan2021, her arm was still sore, it was warm, she had quite a rash, it was red, right where the injection was made, the rest was more pink.  The patient outcome of headache was recovered on 24Jan2021, the outcome of the other events was not recovered.
Within 8 hrs of the vaccine, patient's arm turned very sore and bright red. Injection site was very hot as well.
Tingling and  numbness in fingers. Loss of dexterity and coordination in fingers, weak hands and arms.  Slowly progressed becoming severly  dilbilitating.  Second dose on January 3,2022.  Toes are numb and tingling.  Uncoordinated ability to walk.  Weakness and fatigue now has me in a state of disability.
INJECTION SITE PAIN THAT RADIATES TO SHOULDER. SAW DOCTOR AND IS NOW ON THERAPY-MD SAID HE HAS SEEN BEFORE WITH FLU VACCINATIONS
Temporary = fever/chills , body aches, severe hip & wrist joint pain, severe headache (onset 15 hours after vaccination, duration 14 hours after onset). Continuing = severe tinnitus, onset 2.5 hours after vaccine, continuing at  3 days post-vaccine. Haven?t reported to my physician yet. Will report on 5/4/21 if tinnitus doesn?t improve.